| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |